This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Intrapreneurship within FLG, Inc. (Spanish version)
Garvin, David A.; Gordon, RachelCase HBS-918S11EntrepreneurshipThis case follows Jenica Fletcher as she rebuilds her company's guitar strings division from the ground up. Convinced that she could turn the division around if given complete independence from corporate headquarters, Fletcher relocated the group, rebranded it as Malenti Strings, repositioned the guitar strings as high-performance products, and transformed Malenti into a fast-growing, profitable business. The case traces Fletcher's key steps in...Starting at €8.20
-
Generation Health: A Pioneer in Genetics Benefit Management (A)
Higgins, Robert F.; Marrazzo, Jeffrey D.; Gordon, RachelCase HBS-810007-EEntrepreneurshipGeneration Health, a pioneer in the new field of genetics benefit management, and newly formed company faces many strategic issues. CEO Per Lofberg is in the midst of negotiating a partnership with a major pharmacy benefit management company. As part of these negotiations, Lofberg must decide whether the time is right for such a strategic partner when Generation Health has only been founded for a year. At the same time, Lofberg must recruit for t...Starting at €8.20
-
Playing with Fire at Sittercity (A), Teaching Note
Wasserman, Noam; Gordon, RachelTeaching Note HBS-810120-EEntrepreneurshipNote: This mini-Teaching Note was created to provide a brief overview of the teaching plan for this case. Please see the upcoming, fuller Teaching Note for an extensive overview of the underlying research, pedagogical approaches, and other teaching issues.Starting at €0.00
-
Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story
Hamermesh, Richard G.; Kucherlapati, Raju; Gordon, RachelCase HBS-810066-EEntrepreneurshipIn May 2007, Amgen Inc. (Amgen) received disappointing news from the European Medicines Agency (EMEA) that its drug Vectibix, developed to fight metastatic colorectal cancer, had been rejected. This was especially surprising news given that a similar rival drug had received approval several years prior. Moreover, Vectibix had also received Food and Drug Administration approval in 2006. During additional trials, Amgen has learned that the Vectibix...Starting at €8.20
-
Playing With Fire at Sittercity (A)
Wasserman, Noam; Gordon, RachelCase HBS-809009-EEntrepreneurshipIn August 2006, Genevieve ("Jeh-neh-veev") Thiers, founder and CEO of Sittercity.com looked over at Dan Ratner, Sittercity's vice president and her boyfriend of five years. It had taken her six long years to build Sittercity into the nation's leading babysitting web service. Thiers had begun Sittercity in 2001 in Boston as a way to connect babysitters and parents online, at a time when no one else had thought to manage care-giving connections via...Starting at €8.20
-
Amylin Pharmaceuticals: Diabetes and Beyond, Teaching Note
Hamermesh, Richard G.; Gordon, RachelTeaching Note HBS-809127-EEntrepreneurshipTeaching Note for [809011].Starting at €0.00
-
Playing With Fire at Sittercity (B)
Wasserman, Noam; Gordon, RachelCase HBS-809010-EEntrepreneurshipTo help her finance her aggressive expansion plans, Genevieve Thiers plans to raise venture capital for the first time. She has spent the last six long years building Sittercity into the nation's leading babysitting web service, larger than all of its competitors combined. In the process, she brought her boyfriend and his sister into the business to help her, and ended up learning important lessons about mixing family and business. Now looking to...Starting at €5.74
-
Amylin Pharmaceuticals: Diabetes and Beyond
Hamermesh, Richard G.; Gordon, RachelCase HBS-809011-EEntrepreneurshipGinger Graham, CEO of Amylin Pharmaceuticals, joined the company with the expectation of taking the company's signature drug, Symlin, to market. However, unforeseen regulatory challenges have put the approval process in jeopardy. At the same time the company has a second drug, Byetta, in its pipeline. Graham must decide how to manage the company's limited resources while also finalizing another deal that has huge future potential. Graham knows th...Starting at €8.20
-
Curt Schilling's Next Pitch
Wasserman, Noam; Bussgang, Jeffrey J.; Gordon, RachelCase HBS-810053-EEntrepreneurshipAs his major-league pitching career was starting to wind down in 2006, baseball all-star Curt Schilling decided to become an entrepreneur. Looking to focus his tenacity and his passion for online role-playing games on a new challenge, he founded an online gaming venture, which later became known as 38 Studios. During the venture's first two years, he built a team of 70 people, including an executive team of business and industry veterans, and lea...Starting at €8.20
-
Plavix: Drugs in the Age of Personalized Medicine
Hamermesh, Richard G.; Aspinall, Mara G.; Gordon, RachelCase HBS-811001-EEntrepreneurshipPIavix, one of the world's best selling drugs in 2010, appears to have a limited future. Its patent was due to expire soon and recently new data had been discovered which indicated that a small subset of the population would be at risk for stroke, heart attack or even death if they took PIavix. As a result the FDA had added a black box warning-the agency's most severe--to Plavix's label in 2010. In addition, it had been discovered that the common...Starting at €8.20